Tuis4DX • ASX
4DMedical Ltd
$0,63
27 Sep., 19:00:00 GMT+10 · AUD · ASX · Vrywaring
AandeelAU-gelyste effek
Vorige sluiting
$0,45
Dagwisseling
$0,53 - $0,67
Jaarwisseling
$0,41 - $1,10
Markkapitalisasie
255,76 m AUD
Gemiddelde volume
334,14 k
P/V-verhouding
-
Dividend-opbrengs
-
Primêre beurs
ASX
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
(AUD)Jun. 2024J/J-verandering
Inkomste
1,48 m1 172,70%
Bedryfskoste
12,56 m11,42%
Netto inkomste
-10,19 m-33,78%
Netto winsgrens
-687,8489,49%
Wins per aandeel
——
EBITDA
-11,09 m-5,51%
Effektiewe belastingkoers
-0,01%—
Totale bates
Totale aanspreeklikheid
(AUD)Jun. 2024J/J-verandering
Kontant en korttermynbeleggings
30,61 m-56,01%
Totale bates
120,02 m29,16%
Totale aanspreeklikheid
49,09 m128,71%
Totale ekwiteit
70,93 m—
Uitstaande aandele
410,39 m—
Prys om te bespreek
2,62—
Opbrengs op bates
-23,28%—
Opbrengs op kapitaal
-36,73%—
Netto kontantverandering
(AUD)Jun. 2024J/J-verandering
Netto inkomste
-10,19 m-33,78%
Kontant van bedrywe
-8,06 m8,54%
Kontant van beleggings
-339,48 k-21,29%
Kontant van finansiering
-233,98 k-101,11%
Netto kontantverandering
-8,64 m-172,48%
Beskikbare kontantvloei
-5,43 m13,25%
Meer oor
4DMedical is a medical technology company, based in Australia and the United States. 4DMedical created X-ray Velocimetry Lung Ventilation Analysis Software based on the company's proprietary XV Technology. XV Technology uses patented algorithms adapted from advanced aerodynamics research to process and enhance X-ray and Computed Tomography images. Airflow is measured throughout all regions of the lung, across all phases of the breath—providing clinicians with quantitative lung ventilation data in a report. 4DMedical has commercialized its XV Technology via a Software as a Service model, where patients are scanned using existing imaging equipment and analyzed by 4DMedical remotely. Airflow is measured throughout all regions of the lung, across all phases of the breath, delivering the capability to quantify regional lung function throughout the respiratory cycle, at every location within the lung. The lung function data is provided to clinicians and patients in a report that includes color-coded lung images. This approach enables the detection of subtle functional losses before lung structure is irreversibly effected by the disease. Wikipedia
Gestig
2013
Werknemers
131
Search
Vee soektog uit
Maak soekkassie toe
Google-programme
Hoofkieslys